Allergy Therapeutics plc (AIM: AGY)
4.180
-0.120 (-2.79%)
Sep 11, 2024, 12:59 PM GMT+1
Allergy Therapeutics Balance Sheet
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
Cash & Equivalents | 13.52 | 14.85 | 20.52 | 40.27 | 36.96 | 27.44 | Upgrade
|
Cash & Short-Term Investments | 13.52 | 14.85 | 20.52 | 40.27 | 36.96 | 27.44 | Upgrade
|
Cash Growth | -11.02% | -27.64% | -49.06% | 8.96% | 34.70% | 76.66% | Upgrade
|
Accounts Receivable | 9.93 | 2.37 | 2.69 | 2.96 | 3.49 | 4.49 | Upgrade
|
Other Receivables | - | 2.69 | 3.21 | 1.66 | 2.16 | 4 | Upgrade
|
Receivables | 9.93 | 5.06 | 5.91 | 4.62 | 5.65 | 8.49 | Upgrade
|
Inventory | 11.89 | 11.59 | 11.41 | 10.84 | 10.13 | 9.41 | Upgrade
|
Prepaid Expenses | - | 2.03 | 4.56 | 1.6 | 2.42 | 1.28 | Upgrade
|
Other Current Assets | - | - | - | 0.53 | - | - | Upgrade
|
Total Current Assets | 35.35 | 33.53 | 42.39 | 57.86 | 55.17 | 46.63 | Upgrade
|
Property, Plant & Equipment | 23.39 | 23.24 | 20.19 | 19.72 | 20.42 | 11.48 | Upgrade
|
Goodwill | 3.36 | 3.35 | 3.35 | 3.34 | 3.47 | 3.43 | Upgrade
|
Other Intangible Assets | 1.63 | 1.79 | 1.69 | 1.41 | 1.27 | 1.41 | Upgrade
|
Other Long-Term Assets | 5.35 | 4.87 | 5.33 | 5.76 | 5.9 | 5.55 | Upgrade
|
Total Assets | 69.08 | 66.77 | 72.95 | 88.09 | 86.23 | 68.5 | Upgrade
|
Accounts Payable | 20.09 | 4.09 | 4.28 | 2.9 | 2.22 | 4.14 | Upgrade
|
Accrued Expenses | - | 12.49 | 11.34 | 13.55 | 12.86 | 11.46 | Upgrade
|
Current Portion of Long-Term Debt | 0.64 | 0.65 | 0.95 | 0.96 | 0.83 | 0.69 | Upgrade
|
Current Portion of Leases | 1.12 | 1.16 | 1.32 | 0.79 | 1.44 | - | Upgrade
|
Other Current Liabilities | 3.43 | 0.18 | 0.16 | 0.03 | 0.89 | 0.56 | Upgrade
|
Total Current Liabilities | 25.27 | 18.57 | 18.05 | 18.23 | 18.23 | 16.86 | Upgrade
|
Long-Term Debt | 0.95 | 26.44 | 1.5 | 2.45 | 2.93 | 1.74 | Upgrade
|
Long-Term Leases | 7.15 | 7.75 | 6.76 | 6.97 | 6.99 | - | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.46 | 0.45 | 0.41 | 0.41 | 0.47 | 0.32 | Upgrade
|
Other Long-Term Liabilities | 0.1 | 3.58 | 0.14 | 0.21 | 0.3 | 0.27 | Upgrade
|
Total Liabilities | 42.62 | 64.7 | 35.18 | 39.55 | 42.44 | 30.94 | Upgrade
|
Common Stock | 4.78 | 0.68 | 0.64 | 0.64 | 0.64 | 0.64 | Upgrade
|
Additional Paid-In Capital | 154.67 | 119.03 | 112.58 | 112.58 | 112.58 | 112.58 | Upgrade
|
Retained Earnings | -174.69 | -161.87 | -118.54 | -107.4 | -112.96 | -119.18 | Upgrade
|
Comprensive Income & Other | 41.7 | 44.23 | 43.09 | 42.72 | 43.53 | 43.52 | Upgrade
|
Shareholders' Equity | 26.46 | 2.07 | 37.77 | 48.54 | 43.78 | 37.56 | Upgrade
|
Total Liabilities & Equity | 69.08 | 66.77 | 72.95 | 88.09 | 86.23 | 68.5 | Upgrade
|
Total Debt | 9.85 | 35.99 | 10.53 | 11.17 | 12.18 | 2.44 | Upgrade
|
Net Cash (Debt) | 3.67 | -21.14 | 9.99 | 29.1 | 24.78 | 25 | Upgrade
|
Net Cash Growth | -32.28% | - | -65.69% | 17.42% | -0.88% | 100.43% | Upgrade
|
Net Cash Per Share | 0.00 | -0.03 | 0.02 | 0.04 | 0.04 | 0.04 | Upgrade
|
Filing Date Shares Outstanding | 4,766 | 679.1 | 644.1 | 641.77 | 637.29 | 636.17 | Upgrade
|
Total Common Shares Outstanding | 4,766 | 679.1 | 644.1 | 641.77 | 637.29 | 636.17 | Upgrade
|
Working Capital | 10.08 | 14.96 | 24.34 | 39.63 | 36.94 | 29.77 | Upgrade
|
Book Value Per Share | 0.01 | 0.00 | 0.06 | 0.08 | 0.07 | 0.06 | Upgrade
|
Tangible Book Value | 21.47 | -3.07 | 32.73 | 43.78 | 39.05 | 32.72 | Upgrade
|
Tangible Book Value Per Share | 0.00 | -0.00 | 0.05 | 0.07 | 0.06 | 0.05 | Upgrade
|
Land | - | 3.05 | 3.08 | 3.09 | 11.87 | 3.05 | Upgrade
|
Machinery | - | 33.68 | 29.66 | 27.35 | 26.97 | 23.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.